STAT3 and neoplasm: In NKTCL, frequent STAT3/5B activating mutations were detected in primary patient samples and cell lines, and JAK1/2/3 inhibitors potently suppressed cellular proliferation, inhibited tumor growth and induced apoptosis via abrogation of JAK/STAT program [117,118].